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Abstract
Background: Grading of dysplasia, including head and neck lesions, continues to be a hotly
debated subject. It is subjective and lacks intra- and inter-observer reproducibility due to the
insufficiency of validated morphological criteria and the biological nature of dysplasia. Moreover,
due to the absence of a consensus, several systems are currently employed.
Objectives: The aims of this review are to:
1) Highlight the significance of dysplasia and the importance of a valid method for assessing
precursor lesions of the head and neck.
2) Review the different histopathological classification systems for grading intraepithelial lesions of
the head and neck.
3) Discuss and review quality requirements for these grading systems.
Conclusion: Regarding the different classification systems, data concerning the WHO
classification system are the most available in current literature. There is no simple relationship or
overlapping between the classification systems. Further studies should be done to see whether
other systems have advantages above the current WHO system and to discover indications that
could lead to an universal classification system for intraepithelial lesions of the head and neck.
Introduction
Head and neck squamous cell carcinoma (HNSCC) is one
of the most often encountered malignancies; it carries a
bad prognosis.[1,2] To improve survival, adequate diag-
nosis and treatment of precursor lesions is urgently
needed. These precursor lesions are defined as an altered
epithelium with an increased likelihood for progression
to squamous cell carcinoma (SCC). The altered epithe-
lium shows a variety of cytological and architectural
changes that have traditionally brought under the com-
mon denominator dysplasia.[3]
The presence of dysplastic areas in the epithelium of the
upper aerodigestive tract (UADT) is believed to be associ-
ated with a likely progression to cancer. There is evidence
that in an individual lesion, the more severe the dysplasia
the greater the likelihood is of progression to malignancy.
Rarely however, non-dysplastic lesions may also show
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severity of dysplasia cannot be used as a reliable guide for
the treatment of individual cases. Nevertheless, the crude
relationship between grading dysplasia and risk of pro-
gression to malignancy makes dysplasia grading neces-
sary.
Grading of dysplasia, including head and neck lesions,
continues to be a hotly debated subject. It is subjective
and lacks intra- and inter-observer reproducibility due to
the insufficiency of validated morphological criteria and
the biological nature of dysplasia .[8-10] Moreover, due to
the absence of a consensus, several systems are currently
employed.[11]
Nevertheless conventional histopathological evaluation
based on light microscopic examination of hematoxylin &
eosin-stained slides is, in spite of the above mentioned
shortcomings, still the most valid method for assessing
the malignant potential of preneoplastic head and neck
lesions.[4] Moreover, it is important to notice that making
a diagnosis is a prerequisite for selecting the treatment
which ensures the best prognosis, making the disease clas-
sification system a predictive system.[8,12] The aim
should be to tailor forms of therapy to the likelihood of
disease progression thus reducing the incidence of inva-
sive disease, limiting the need for radical surgery and
improving survival while avoiding unnecessary follow-up
in cases which lack significant premalignant poten-
tial.[10]
Grading systems: overview
During the last decades many classifications of intraepi-
thelial head and neck lesions have been proposed as illus-
trated by the fact that for intraepithelial laryngeal lesions,
more than 20 classification systems have been described
.[13-18] This seriously hampers the assessment of the
long-term risk of subsequent malignancy, because differ-
ent histopathological classifications and initial interven-
tions make comparison of reported data difficult or even
impossible because of inconsistencies in the criteria used
for evaluation of the histological features.[8,19,20] The
need for uniformity in reporting these lesions is obvious.
The majority of the classifications in the current literature
have followed criteria similar to those in common use for
the grading of epithelial lesions of the uterine cer-
vix.[21,22] Whether this is justified, is debatable. In cervi-
cal epithelium, there is clear distinction between normal
and abnormal layers of the epithelium and consequently
the degree of dysplasia can be assessed by determining the
horizontal level of this border in the epithelium, resulting
in substantial intra- and inter-observer consistency. Such
a sharp distinction between normal and abnormal layers
in the epithelium of the UADT is less obvious and conse-
quently the definition of the degree of dysplasia is much
more susceptible for discussion, this resulting in substan-
tial intra- and inter-observer variability.[8,10,23]
When looking at the current classification systems as men-
tioned in the WHO-IARC blue book series the following
ones are proposed. The WHO classification is similar to
the classification for the uterine cervix, and is widely used
in spite of the shortcomings as mentioned. It recognizes
low, moderate and severe dysplasia and carcinoma in situ
(CIS), defined in the same way as for cervical lesions. The
SIN classification (squamous intraepithelial neoplasia)
can be considered synonymously, excepted that severe
dysplasia and CIS are combined as SIN 3 (Table 1).
Besides the WHO and SIN classification system, the
Ljubljana classification is mentioned (Table 1).[3,11]
The Ljubljana classification, developed by laryngeal
pathologists and used since 1971, focuses on the clinical
Table 1: Classification systems that categorize intraepithelial head and neck lesions.[3,11]
2005 WHO Classification Squamous Intraepithelial Neoplasia (SIN) Ljubljana Classification Squamous Intraepithelial Lesions 
(SIL)
squamous cell hyperplasia squamous cell (simple) hyperplasia
mild dysplasia SIN 1 basal/parabasal cell hyperplasia*
moderate dysplasia SIN 2 atypical hyperplasia**
severe dysplasia SIN 3*** atypical hyperplasia**
carcinoma in-situ SIN 3*** carcinoma in-situ
* basal/parabasal cell hyperplasia may histologically resemble mild dyplasia, but the former is conceptually benign lesion and the latter the lower 
grade of precursor lesions.
** 'risky epithelium'. The analogy to moderate and severe dysplasia is approximate.
*** the advocates of SIN combine severe dysplasia and carcinoma in-situ.Page 2 of 8
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purely hyperplastic lesions that do not require close fol-
low-up (simple or abnormal hyperplasia), 2) mild
degrees of atypia who require close follow-up to recognize
any progression to severe atypia (atypical or 'risky' hyper-
plasia), 3) severe atypia (carcinoma in situ) who require
treatment (surgery or radiotherapy).[4,16,19,24,25]
Apart from these taxonomic problems, the need to differ-
entiate between severe dysplasia and carcinoma in situ is
debatable. Several authors have commented on the diffi-
culty in separating these categories in conventional classi-
fication systems.[4,5,13] To reduce categories still further,
occasionally a binary classifying system has been pro-
posed.[10,26]
Quality requirements for grading systems
A grading system can be devised in two ways: an arbitrary
system can be composed with no detailed knowledge of
the domain, or data about the domain can be used in sta-
tistical methods of analysis. Since most grading and scor-
ing systems in histopathology are imposed on domains
without prior data analysis, the psychological factors that
affect the creation of these systems becomes important.
There is often an interaction between histopathological
grading systems and clinical therapies especially if trials of
treatment for a particular condition are widespread. Some
authors suggest that the pathologist is required only to
divide cases into the number of different treatment
options available. Others, including Morris, argue that the
pathologist should transmit the maximum amount of
information possible from their interpretations without
the addition of extraneous 'noise'.[27,28] Furthermore,
reproducibility and prognostic value (use of results) are
important conditions.
Reproducibility
Reproducibility refers to the degree to which observer
measurement or diagnosis remains the same on repeated
independent observations of an unchanged characteris-
tic.[29] This consistency can be assessed between different
observers (interobserver) or within a single observer
(intraobserver). When studying the accuracy in grading
dysplasia of the UADT there is no test available, which is
thought to be better than the pathologist's observation; an
accepted gold standard is not available for assessing the
validity obtained when grading these lesions. Therefore,
reproducibility, normally used to assess precision, is used
to provide an indication of validity. When combined for
this goal, inter- and intraobserver agreement levels give an
estimate of the degree of bias and validity in situations
(like grading dysplasia of the UADT), where an appropri-
ate gold standard is not available.[30]
If a scoring system is to be clinically useful then it should
be reproducible both between pathologists and for the
same pathologist at different times: inter- and intra-
observer reproducibility.[27] In histopathology, results of
the diagnostic evaluation are discrete diagnostic catego-
ries (for example, moderate dysplasia in a laryngeal
lesion) rather than variable parameters and for this reason
kappa statistics are often used as indicators of perform-
ance .[31-33] Kappa statistics measure levels of agreement
between observers and make allowance for the degree of
agreement that would occur by chance alone.[34] Since
most grading systems in squamous lesions produce an
ordinal categorical result then kappa statistics are a rele-
vant means of assessing reproducibility.[8,27,32,34,35] A
kappa statistic of 1 represents perfect agreement and 0 rep-
resents the level of agreement expected by chance
alone.[27] Landis et al. described guidelines to interpret
the quantitative significance of kappa.[31]
Concerning the head and neck region, data of oral lesions
outnumber laryngeal lesions. Pindborg et al. for the first
time indicated the need for an internationally accepted set
of criteria for oral epithelial dysplasia in 1975.[36] Since
then, several studies have shown large intra- and interob-
server variability in the assessment of intraepithelial head
and neck lesions (Table 2).[10,26,30,36-41]
There are also additional features that negatively influence
reproducibility. Fischer et al. suggested that inflamma-
tion, lesion site, and biopsy technique (punch and wedge)
modifies the reliability of oral histological lesions.[38]
Clinical information submitted with biopsy specimens
did not increase accuracy and consistency.[41]
With these considerations in mind, reproducibility for the
larynx gave an overall kappa value of 0.32 for the WHO
classification, whereas the use of a two grade system (low
and high grade) gave a kappa figure of 0.52.[10] Data con-
cerning the SIN classification and Ljubljana classification
in relation to reproducibility of laryngeal lesions are not
available in current literature. Agreement for lesions of the
oral cavity and oropharynx varies from 35.8 to 92.8% for
the WHO classification, kappa values varying from 0.15 to
0.59.[26,30,37-41] A binary system (high/low risk), eval-
uated by Kujan et al., resulted in 74.3% agreement and a
kappa value of 0.50. Particularly for the cases of moderate
dysplasia the binary grading system may have merit in
helping clinicians to make critical decisions.[26] Fischer et
al. also reduced the number of pathologic diagnoses to
three categories ('no abnormality/hyperkeratosis', 'mild,
moderate, or severe dysplasia', 'carcinoma in situ/carci-
noma') which resulted in a kappa value of 0.70 (com-
pared with 0.59 using the various pathologic diagnoses
separately).[38] Data concerning the SIN classification
and Ljubljana classification in relation to reproducibilityPage 3 of 8
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not available in current literature. Table 2 shows an over-
view of observer variability in head and neck lesions.
Prognostic and predictive value
Altmann et al. and Putney et al. reported the first follow-
up studies of precancerous conditions of the larynx; carci-
noma in situ and keratosis, respectively.[42,43] Since then
several follow-up studies concerning the natural evolu-
tion and long-term risk of malignant progression in
intraepithelial lesions have been reported. In these stud-
ies, usually no distinction between natural evolution
without treatment (prognostic value) and predictive value
(response to treatment) is made. Therefore, data on malig-
nant progression as summarized below concern both
treated and untreated cases.
Malignant progression of intraepithelial laryngeal lesions
diagnosed with the WHO classification is, according to
current literature, as follows: hyperplasia 0–
3%.[13,44,45], mild dysplasia 0–30% [13,45-47], moder-
ate dysplasia 0–44% [5,13,45-49], severe dysplasia 20–
57% [13,45,47,49,50], CIS 0–80% [13,44,45,48-52].
Regarding the SIN classification, relevant figures are as fol-
lows: SIN I 5%, SIN II 25%, and SIN III 11–25%.[5,53]
Table 2: Observer variability in head and neck lesions.
Studies/
References







Abbey et al. 1995 oral cavity/
oropharynx
120 WHO° 6 35.8–57.5% 0.15–0.41
Fischer et al. 20041 oral cavity/
oropharynx
87 WHO° 24 0.59 
(95% CI: 0.45–
0.72)
0.70 (95% CI: 
0.56–0.84)2




100 WHO° 4 49–69% 27–45%3
Tabor et al. 2003 oral cavity/
oropharynx
43 WHO 3 53% 0.58
Abbey et al. 1998 oral cavity/
oropharynx
120 WHO° 6 38.5% 0.174




64 WHO° 3 51% 0.37
Kujan et al. 20061 oral cavity/
oropharynx











0.22 (95% CI: 
0.11–0.35 
unweighted)





Mclaren et al. 2000 larynx 100 WHO and two-
grade 




° = WHO is not explicitely stated, but terms are in agreement with this system.
1 = The unweighted kappa considers all disagreements to be equally important, while the weighted kappa (Kw) yields a higher reliability when 
disagreements between raters are small compared with when they are large.
2 = the pathologic diagnoses are restricted to three categories ('no abnormality/hyperkeratosis', 'mild, moderate, or severe dysplasia', 'carcinoma in 
situ/carcinoma').
3 = when comparing the kappa values between the two pairs of pathologists with the same education, these values did not diverge from the general 
level of kappa values, indicating that the interobserver variability was due to individual differences rather than to educational background.
4 = Clinical information submitted with biopsy. Same population as [37].Page 4 of 8
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Head & Neck Oncology 2009, 1:11 http://www.headandneckoncology.org/content/1/1/11Photomicrograph showing area of increased epithelial thick-ness togethe  with yperkeratosis: mild dysplas a (WHO) or parabasal yperpla ia (Ljubljan )Figure 1
Photomicrograph showing area of increased epithe-
lial thickness together with hyperkeratosis: mild dys-
plasia (WHO) or parabasal hyperplasia (Ljubljana).
Photomicrograph showing blunt and elongated epithelial ridges and cytonuclear atypia confined to the lower ep thelial half: moderate dyspl si  (WHO) or atypical hyperplasi  (Ljubljana)Figure 2
Photomicrograph showing blunt and elongated epi-
thelial ridges and cytonuclear atypia confined to the 
lower epithelial half: moderate dysplasia (WHO) or 
atypical hyperplasia (Ljubljana).
Clinical data concerning follow-up on laryngeal lesions
graded with the Ljubljana classification showed a marked
increase in the incidence of malignant progression from
simple, abnormal, and atypical hyperplasia (resp. 0.7%,
1.0%, and 9.5%).[25] Recently, a study by Gale et al.
showed 1.1% (12/1089) progression to carcinoma of
squamous hyperplasia/basal-parabasal hyperplasia and
9.5% (17/179) of atypical hyperplasia (CIS is not
included).[20]
Few studies have examined the cancer risk related to dif-
ferent grades of oral dysplasias .[54-57] Silverman et al.
reported malignant transformation in 36% of cases with
oral dysplasia. The degree of dysplasia is not speci-
fied.[56] Schepman et al. reported 12% malignant trans-
formation in oral lesions histopathological classified with
the WHO classification. Leukoplakias consisting of mod-
erate or severe epithelial dysplasia, had a significantly
higher risk of developing a carcinoma than leukoplakias
of a lower stage (p < 0.01).[55] In another study 26% of
cases with hyperplasia/mild dysplasia and 67% of cases
with moderate/severe dysplasia developed into carci-
noma.[54] Lumerman et al. studied malignant transfor-
mation in hyperplasia with dysplasia, mild dysplasia,
moderate dysplasia, severe dysplasia, and CIS; respec-
tively 29%, 8%, 17%, 17%, 0%.[57] Data concerning the
SIN classification in relation to predictive value of oral
lesions are not available in current literature. The only
study in current literature which studied the application
of the Ljubljana classification to grading oral intraepithe-
lial lesions has been published by Zerdoner et al. No cases
of simple (0/79) or abnormal (0/42) hyperplasia showed
progression to carcinoma, 18.2% (2/11) of atypical hyper-
plasia progressed to invasive cancer.[58]
Interpretation of these reported data of oral intraepithelial
lesions are hampered by small sample sizes, surgical inter-
vention carried out for high-risk dysplasias and variability
in reporting dysplasia grades. The greater part of pub-
lished data only considered macroscopical features (i.e.
leukoplakia) and no histology.[59,60] It should also be
noted that the predictive value of dysplasia is dependent
on the prevalence of leukoplakia in a given population.[8]
Size, and not histology seems to be the most important in
predicting malignant transformation.[61]
So, it appears that regarding reproducibility as well as in
terms of prognosis, still a lot of progress has to be made.
Molecular markers are subject of investigation: in spite of
many studies, the molecular events that induce the devel-
opment of premalignancies to carcinoma are still
unknown, and we are still forced to conclude that over (orPage 5 of 8
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tive value over standard histology .[62-66] Therefore,
until now they are not applicable in clinical practice.[67]
Finally, some remarks have to be made on the relation-
ship between clinical aspects and risk of malignant pro-
gression. In general, homogeneous leukoplakic lesions
are thought to have a low risk of malignant transforma-
tion, mixed white and red lesions (or speckled leukopla-
kia) an intermediate risk, and pure erythroplakia (red
lesions) the highest risk of cancer development. However,
none of these macroscopic features is reliably diagnostic
of any histological grade of precursor lesion, and histolog-
ical analysis of these lesions is mandatory to determine
their biological potential. Occasionally precursor lesions
may appear clinically normal.[3,11,20,68] Furthermore,
nomenclature or terminology concerning the macro-
scopic features is still a subject of discussion.[69]
Evaluation
As outlined before, a histological dysplasia system ideally
should meet two basic requirements. At first, it should be
easily applicable in daily routine practice with low inter-
and intra-observer variability. Secondly, it should allow a
clear separation between patients who need treatment to
prevent progression towards malignancy and those for
whom no treatment is needed.
Regarding inter- and intraobserver variability, evaluation
of the WHO classification shows for laryngeal lesions an
overall kappa value of 0.32, whereas the use of a two grade
system (low and high grade) gave a kappa figure of
0.52.[10] Its prognostic significance is as follows: hyper-
plasia 0–3%.[13,44,45], mild dysplasia 0–30% [13,45-
47], moderate dysplasia 0–44% [5,13,45-49], severe dys-
plasia 20–57% [13,45,47,49,50], CIS 0–80%
[13,44,45,48-52]. For oral lesions, inter- and intraob-
server figures of the WHO classification vary between
kappa scores of 0.15 and 0.59.[26,30,37-41] Its prognos-
tic significance is 12–67%, as can be inferred from the
data mentioned before.
When looking at the SIN classification it has to be noted,
that with respect to reproducibility, no data of head and
neck lesions are available in current literature. Concerning
prognostic significance of laryngeal lesions the following
data are available: SIN I 5%, SIN II 25%, SIN III 11–
25%.[5,53] Data concerning the SIN classification in rela-
tion to predictive value of oral lesions are not available in
current literature.
Regarding the Ljubljana classification, its use for the lar-
ynx has been documented extensively. Its relevance for
prognosis has been amply demonstrated by the patholo-
gists and clinicians who developed the system. However,
its usefulness has not yet resulted in widespread accept-
ance. For the oral cavity, there is only one study that
reports its use in this anatomic location.[58] In that study
a prognostic significance, similar to the larynx was noted.
However, data on reproducibility are also lacking for this
anatomic area. Further studies should be done to see
whether it has an advantage above the current WHO dys-
plasia system.
Although the histological assessment of the WHO dyspla-
sia system and the Ljubljana system are based on the same
architectural and cytological changes, there is no simple
relationship or overlapping between the classification sys-
tems.[3,11,19,20] Figure 1, figure 2, and figure 3 illustrate
the areas of similarity in the classification systems but also
the problems arising when matching the WHO categories
moderate and severe dysplasia with the Ljubljana category
atypical hyperplasia. According to Gale et al., comparing
the three discussed classification systems, it is unlikely
that they will come together in the very near future. On
the other hand, future discoveries mainly in molecular
biology could be the basis for a single, universal classifica-
tion system for intraepithelial lesions of the UADT.[20]
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
All authors read and approved the final manuscript.
References
1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ: Cancer
statistics, 2008.  CA Cancer J Clin 2008, 58:71-96.
Photomicrograph showing epithelial alterations involving the entire epitheli l thickness: sever  dysplasi  (WHO) or atypi-cal hyp rplasia (Ljubljana)Figure 3
Photomicrograph showing epithelial alterations 
involving the entire epithelial thickness: severe dys-
plasia (WHO) or atypical hyperplasia (Ljubljana).Page 6 of 8
(page number not for citation purposes)
Head & Neck Oncology 2009, 1:11 http://www.headandneckoncology.org/content/1/1/112. Forastiere A, Koch W, Trotti A, Sidransky D: Head and neck can-
cer.  N Engl J Med 2001, 345:1890-1900.
3. Gale N, Pilch BZ, Sidransky D, Westra W, Califano J: Tumours of
the hypopharynx, larynx and trachea (Epithelial precursor
lesions).  In World Health Organization Classification of Tumours. Pathol-
ogy & genetics. Head and neck tumours. International Agency for Research
on Cancer (IARC) Edited by: Barnes L, Eveson JW, Reichart P, Sidransky
D. Lyon: IARC Press; 2005:140-143.
4. Helliwell TR: 'Risky' epithelium in the larynx – a practical diag-
nosis?  Histopathology 1999, 34:262-265.
5. Hellquist H, Lundgren J, Olofsson J: Hyperplasia, keratosis, dys-
plasia and carcinoma in situ of the vocal cords – a follow-up
study.  Clin Otolaryngol Allied Sci 1982, 7:11-27.
6. Pindborg JJ, Reichart P, Smith CJ, Waal I van der: World Health Organ-
ization: histological typing of cancer and precancer of the oral mucosa Ber-
lin: Springer-Verlag; 1997. 
7. Stenersen TC, Hoel PS, Boysen M: Carcinoma in situ of the lar-
ynx: an evaluation of its natural clinical course.  Clin Otolaryngol
Allied Sci 1991, 16:358-363.
8. Warnakulasuriya S, Reibel J, Bouquot J, Dabelsteen E: Oral epithe-
lial dysplasia classification systems: predictive value, utility,
weaknesses and scope for improvement.  J Oral Pathol Med
2008, 37:127-133.
9. Bosman FT: Dysplasia classification: pathology in disgrace?  J
Pathol 2001, 194:143-144.
10. McLaren KM, Burnett RA, Goodlad JR, Howatson SR, Lang S, Lee FD,
Lessells AM, Ogston S, Robertson AJ, Simpson JG, Smith GD, Tavadia
HB, Walker F, Scottish Pathology Consistency Group: Consistency
of histopathological reporting of laryngeal dysplasia. The
Scottish Pathology Consistency Group.  Histopathology 2000,
37:460-463.
11. Gale N, Pilch BZ, Sidransky D, El-Naggar AK, Westra W, Califano J,
et al.: Tumours of the oral cavity and oropharynx (Epithelial
precursor lesions).  In World Health Organization Classification of
Tumours. Pathology & genetics. Head and neck tumours. International
Agency for Research on Cancer (IARC) Edited by: Barnes L, Eveson JW,
Reichart P, Sidransky D. Lyon: IARC Press; 2005:177-179. 
12. Wulff HR, Gotzsche PC: Rational Diagnosis and Treatment.
Evidence-Based Clinical Decision-Making.  Oxford: Blackwell
Scientific Publications; 1981:68. 
13. Blackwell KE, Fu YS, Calcaterra TC: Laryngeal dysplasia. A clin-
icopathologic study.  Cancer 1995, 75:457-463.
14. Gale N, Kambic V, Michaels L, Cardesa A, Hellquist H, Zidar N, Poljak
M: The Ljubljana classification: a practical strategy for the
diagnosis of laryngeal precancerous lesions.  Adv Anat Pathol
2000, 7:240-251.
15. Kambic V, Gale N: Significance of keratosis and dyskeratosis
for classifying hyperplastic aberrations of laryngeal mucosa.
Am J Otolaryngol 1986, 7:323-333.
16. Kambic V: Epithelial hyperplastic lesions – a challenging topic
in laryngology.  Acta Otolaryngol Suppl 1997, 527:7-11.
17. Sengiz S, Pabuccuoglu U, Sarioglu S: Immunohistological compar-
ison of the World Health Organization (WHO) and
Ljubljana classifications on the grading of preneoplastic
lesions of the larynx.  Pathol Res Pract 2004, 200:181-188.
18. Vodovnik A, Gale N, Kambic V, Luzar B: Correlation of histomor-
phological criteria used in different classifications of epithe-
lial hyperplastic lesions of the larynx.  Acta Otolaryngol Suppl
1997, 527:116-119.
19. Hellquist H, Cardesa A, Gale N, Kambic V, Michaels L: Criteria for
grading in the Ljubljana classification of epithelial hyperplas-
tic laryngeal lesions. A study by members of the Working
Group on Epithelial Hyperplastic Laryngeal Lesions of the
European Society of Pathology.  Histopathology 1999,
34:226-233.
20. Gale N, Michaels L, Luzar B, Poljak M, Zidar N, Fischinger J, Cardesa
A: Current review on squamous intraepithelial lesions of the
larynx.  Histopathology 2009, 54(6):639-656.
21. Richart RM: Natural history of cervical intraepithelial neopla-
sia.  Clin Obstet Gynecol 1967, 10:748-784.
22. Scully RE, Bonfiglio TA, Kurman RJ, Silverberg SG, Wilkinson : Histo-
logical typing of female genital tract tumours (International histological clas-
sification of tumours) Berlin: Springer; 1994. 
23. Bouquot JE, Speight PM, Farthing PM: Epithelial dysplasia of the
oral mucosa-Diagnostic problems and prognostic features.
Current Diagnostic Pathology 2006, 12:11-21.
24. Kambic V, Lenart I: [Our classification of hyperplasia of the
laryngeal epithelium from the prognostic point of view].  J Fr
Otorhinolaryngol Audiophonol Chir Maxillofac 1971, 20:1145-1150.
25. Kambic V, Gale N: Epithelial hyperplastic lesions of the larynx Amster-
dam: Elsevier; 1995. 
26. Kujan O, Oliver RJ, Khattab A, Roberts SA, Thakker N, Sloan P: Eval-
uation of a new binary system of grading oral epithelial dys-
plasia for prediction of malignant transformation.  Oral Oncol
2006, 42:987-993.
27. Cross SS: Grading and scoring in histopathology.  Histopathology
1998, 33:99-106.
28. Morris JA: Information and observer disagreement in histopa-
thology.  Histopathology 1994, 25:123-128.
29. Houston WJ: The analysis of errors in orthodontic measure-
ments.  Am J Orthod 1983, 83:382-390.
30. Brothwell DJ, Lewis DW, Bradley G, Leong I, Jordan RC, Mock D,
Leake JL: Observer agreement in the grading of oral epithelial
dysplasia.  Community Dent Oral Epidemiol 2003, 31:300-305.
31. Landis JR, Koch GG: The measurement of observer agreement
for categorical data.  Biometrics 1977, 33:159-174.
32. Silcocks P: Some issues in observer error studies in pathology.
J Pathol 1992, 168:255-256.
33. Svanholm H, Starklint H, Gundersen HJ, Fabricius J, Barlebo H, Olsen
S: Reproducibility of histomorphologic diagnoses with special
reference to the kappa statistic.  APMIS 1989, 97:689-698.
34. Cross SS: Kappa statistics as indicators of quality assurance in
histopathology and cytopathology.  J Clin Pathol 1996,
49:597-599.
35. Silcocks PB: Measuring repeatability and validity of histologi-
cal diagnosis – a brief review with some practical examples.
J Clin Pathol 1983, 36:1269-1275.
36. Pindborg JJ, Reibel J, Holmstrup P: Subjectivity in evaluating oral
epithelial dysplasia, carcinoma in situ and initial carcinoma.
J Oral Pathol 1985, 14:698-708.
37. Abbey LM, Kaugars GE, Gunsolley JC, Burns JC, Page DG, Svirsky JA,
Eisenberg E, Krutchkoff DJ, Cushing M: Intraexaminer and
interexaminer reliability in the diagnosis of oral epithelial
dysplasia.  Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995,
80:188-191.
38. Fischer DJ, Epstein JB, Morton TH, Schwartz SM: Interobserver
reliability in the histopathologic diagnosis of oral pre-malig-
nant and malignant lesions.  J Oral Pathol Med 2004, 33:65-70.
39. Karabulut A, Reibel J, Therkildsen MH, Praetorius F, Nielsen HW,
Dabelsteen E: Observer variability in the histologic assessment
of oral premalignant lesions.  J Oral Pathol Med 1995, 24:198-200.
40. Tabor MP, Braakhuis BJ, Wal JE van der, van Diest PJ, Leemans CR,
Brakenhoff RH, Kummer JA: Comparative molecular and histo-
logical grading of epithelial dysplasia of the oral cavity and
the oropharynx.  J Pathol 2003, 199:354-360.
41. Abbey LM, Kaugars GE, Gunsolley JC, Burns JC, Page DG, Svirsky JA,
Eisenberg E, Krutchkoff DJ: The effect of clinical information on
the histopathologic diagnosis of oral epithelial dysplasia.  Oral
Surg Oral Med Oral Pathol Oral Radiol Endod 1998, 85:74-77.
42. Altmann F, Ginsberg I, Stout AP: Intraepithelial carcinoma (can-
cer in situ) of the larynx.  AMA Arch Otolaryngol 1952, 56:121-133.
43. Putney FJ, O'keefe JJ: The clinical significance of keratosis of the
larynx as a premalignant lesion.  Ann Otol Rhinol Laryngol 1953,
62:348-357.
44. Hirade Y, Aso M, Kurita S, Hirano M, Shin T: Epithelial hyperplasia
of the larynx. A 10-year review of 88 patients.  Auris Nasus Lar-
ynx 1983, 10(Suppl):S73-S81.
45. Plch J, Par I, Navratilova I, Blahova M, Zavadil M: Long term follow-
up study of laryngeal precancer.  Auris Nasus Larynx 1998,
25:407-412.
46. Moesgaard NV, Hojslet PE, Palvio D: Reinke's oedema: a prema-
lignant condition?  J Laryngol Otol 1986, 100:1159-1162.
47. Uno Y, Saito R, Hamaya K, Nose S: Epithelial hyperplasia of the
larynx a clinical follow-up study.  Auris Nasus Larynx 1997,
24:309-314.
48. Hojslet PE, Nielsen VM, Palvio D: Premalignant lesions of the lar-
ynx. A follow-up study.  Acta Otolaryngol 1989, 107:150-155.
49. Riera V Jr, Suarez NC, Pedrero de BC, Alvarez MC: Premalignant
lesions of the larynx: pathological prognostic factors.  J
Otolaryngol 1987, 16:367-370.Page 7 of 8
(page number not for citation purposes)
Head & Neck Oncology 2009, 1:11 http://www.headandneckoncology.org/content/1/1/11Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
50. Hellquist H, Olofsson J, Grontoft O: Carcinoma in situ and
severe dysplasia of the vocal cords. A clinicopathological and
photometric investigation.  Acta Otolaryngol 1981, 92:543-555.
51. Stenersen TC, Hoel PS, Boysen M: Carcinoma in situ of the lar-
ynx. Results with different methods of treatment.  Acta
Otolaryngol Suppl 1988, 449:131-133.
52. Hintz BL, Kagan AR, Nussbaum H, Rao AR, Chan PY, Miles J: A
'watchful waiting' policy for in situ carcinoma of the vocal
cords.  Arch Otolaryngol 1981, 107:746-751.
53. Crissman JD, Zarbo RJ: Dysplasia, in situ carcinoma, and pro-
gression to invasive squamous cell carcinoma of the upper
aerodigestive tract.  Am J Surg Pathol 1989, 13(Suppl 1):5-16.
54. Lee JJ, Hong WK, Hittelman WN, Mao L, Lotan R, Shin DM, Benner
SE, Xu XC, Lee JS, Papadimitrakopoulou VM, Geyer C, Perez C, Mar-
tin JW, El-Naggar AK, Lippman SM: Predicting cancer develop-
ment in oral leukoplakia: ten years of translational research.
Clin Cancer Res 2000, 6:1702-1710.
55. Schepman KP, Meij EH van der, Smeele LE, van dWI: Malignant
transformation of oral leukoplakia: a follow-up study of a
hospital-based population of 166 patients with oral leukopla-
kia from The Netherlands.  Oral Oncol 1998, 34:270-275.
56. Silverman S Jr, Gorsky M, Lozada F: Oral leukoplakia and malig-
nant transformation. A follow-up study of 257 patients.  Can-
cer 1984, 53:563-568.
57. Lumerman H, Freedman P, Kerpel S: Oral epithelial dysplasia and
the development of invasive squamous cell carcinoma.  Oral
Surg Oral Med Oral Pathol Oral Radiol Endod 1995, 79:321-329.
58. Zerdoner D: The Ljubljana classification – its application to
grading oral epithelial hyperplasia.  J Craniomaxillofac Surg 2003,
31:75-79.
59. Napier SS, Speight PM: Natural history of potentially malignant
oral lesions and conditions: an overview of the literature.  J
Oral Pathol Med 2008, 37:1-10.
60. Reibel J: Prognosis of oral pre-malignant lesions: significance
of clinical, histopathological, and molecular biological char-
acteristics.  Crit Rev Oral Biol Med 2003, 14:47-62.
61. Holmstrup P, Vedtofte P, Reibel J, Stoltze K: Long-term treatment
outcome of oral premalignant lesions.  Oral Oncol 2006,
42:461-474.
62. Cowan JM, Beckett MA, hmed-Swan S, Weichselbaum RR: Cytoge-
netic evidence of the multistep origin of head and neck squa-
mous cell carcinomas.  J Natl Cancer Inst 1992, 84:793-797.
63. Perez-Ordonez B, Beauchemin M, Jordan RC: Molecular biology of
squamous cell carcinoma of the head and neck.  J Clin Pathol
2006, 59:445-453.
64. Staibano S, Merolla F, Testa D, Iovine R, Mascolo M, Guarino V, Cas-
tellone MD, Di Benedetto M, Galli V, Motta S, Melillo RM, De Rosa
G, Santoro M, Celetti A: OPN/CD44v6 overexpression in laryn-
geal dysplasia and correlation with clinical outcome.  Br J Can-
cer 2007, 97:1545-1551.
65. Zukerberg L: The molecular basis of dysplasia.  Semin Diagn
Pathol 2002, 19:48-53.
66. Koren R, Kristt D, Shvero J, Yaniv E, Dekel Y, Gal R: The spectrum
of laryngeal neoplasia: the pathologist's view.  Pathol Res Pract
2002, 198:709-715.
67. Kim MM, Califano JA: Molecular pathology of head-and-neck
cancer.  Int J Cancer 2004, 112:545-553.
68. Wenig BM: Squamous cell carcinoma of the upper aerodiges-
tive tract: precursors and problematic variants.  Mod Pathol
2002, 15:229-254.
69. Warnakulasuriya S, Johnson NW, van dWI: Nomenclature and
classification of potentially malignant disorders of the oral
mucosa.  J Oral Pathol Med 2007, 36:575-580.Page 8 of 8
(page number not for citation purposes)
